Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date01 Jan 1985 |
100 Clinical Results associated with Guangxi LMZ Ecan Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Guangxi LMZ Ecan Pharmaceutical Co., Ltd.
100 Deals associated with Guangxi LMZ Ecan Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Guangxi LMZ Ecan Pharmaceutical Co., Ltd.